Your account is not claimed yet. You can sign up with ORCID to claim your account.

Andreas Clemens

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Science translational medicine

PloS one

Eye (London, England)

International journal of chronic obstructive pulmonary disease

Novartis Pharma AG

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Novartis Pharma AG

Switzerland

Regional Medical Director :: Medicine Region Europe

Publications

Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, Marie Fichter, Brigitte Christen, Tina Rubic-Schneider, Stephan Koepke, Benjamin Cochin de Billy, David Ledieu, Cedric Andre, Stuart Hawtin, Benoit Fischer, Francesca Moretti, Christian Hug, Alexander Bepperling, Barbara Brannetti, Celia Mendez-Garcia, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees, Anette C Karle
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, Marie Fichter, Brigitte Christen, Tina Rubic-Schneider, Stephan Koepke, Benjamin Cochin de Billy, David Ledieu, Cedric Andre, Stuart Hawtin, Benoit Fischer, Francesca Moretti, Christian Hug, Alexander Bepperling, Barbara Brannetti, Celia Mendez-Garcia, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees, Anette C Karle
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab. Science translational medicine 15 (681) (2023)
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, Marie Fichter, Brigitte Christen, Tina Rubic-Schneider, Stephan Koepke, Benjamin Cochin de Billy, David Ledieu, Cedric Andre, Stuart Hawtin, Benoit Fischer, Francesca Moretti, Christian Hug, Alexander Bepperling, Barbara Brannetti, Celia Mendez-Garcia, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees, Anette C Karle
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Andrew John Lotery, Andreas Clemens, Raman Tuli, Xun Xu, Masahiko Shimura, Marco Nardi, Manuela Schmidt, Cornelia Dunger-Baldauf, Ramin Tadayoni, null null
Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study. Eye (London, England) (2021)
Frank G Holz, Rodrigo Abreu-Gonzalez, Francesco Maria Bandello, Renaud Duval, Louise O'Toole, Daniel Pauleikhoff, Giovanni Staurenghi, Armin Wolf, Daniel Lorand, Andreas Clemens, Benjamin Gmeiner
Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL study. The British journal of ophthalmology (2021)
Laurent Kodjikian, Mariacristina Parravano, Andreas Clemens, Rosa Dolz-Marco, Frank G Holz, Marion R Munk, Massimo Nicolò, Federico Ricci, Rufino Silva, S James Talks, Rohini Kumar Verma, Javier Zarranz-Ventura, Sandrine Anne Zweifel
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations. Eye (London, England) 35 (8) (2021)
Konstantinos Kostikas, David J Price, Florian S Gutzwiller, Bethan I Jones, Emil Loefroth, Andreas Clemens, Robert Fogel, Rupert C Jones, Hui Cao
Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database. International journal of chronic obstructive pulmonary disease 15 (2020)
Ian Pearce, Andreas Clemens, Michael H Brent, Lin Lu, Roberto Gallego-Pinazo, Angelo Maria Minnella, Catherine P Creuzot Garcher, Georg Spital, Taiji Sakamoto, Cornelia Dunger-Baldauf, Ian L McAllister, null null
Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study. PloS one 15 (6) (2020)
Robin D Hamilton, Andreas Clemens, Angelo Maria Minnella, Timothy Y Y Lai, Hong Dai, Taiji Sakamoto, Chui Ming Gemmy Cheung, Nor Fariza Ngah, Cornelia Dunger-Baldauf, Frank G Holz, null null
Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study. PloS one 15 (1) (2020)
David J Price, Jaco Voorham, Guy Brusselle, Andreas Clemens, Konstantinos Kostikas, Jeffrey W Stephens, Hye Yun Park, Nicolas Roche, Robert Fogel
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. NPJ primary care respiratory medicine 29 (1) (2019)

Andreas Clemens.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andreas Clemens